|
Estimation of Incidence and Evaluation of Clinical and Paraclinical Features of Cystic Fibrosis: A Rare Disease in Kurdistan Province between 2010 and 2020
|
Hero Yazdanpanah1    , Pedram Ataee2 , Manouchehr Ahmadi Hedayati3 , Karo Servatyari1 , Khaled Rahmani 4 |
1- MD student, Student Research Committee, Kurdistan University of Medical Science, Sanandaj, Iran
2- Assistant Professor, Department of Pediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Assistant Professor, Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
4- Assistant Professor, Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran , khaledrahmani111@yahoo.com |
|
|
Abstract: (1068 Views) |
Background and Aim: Cystic fibrosis is a rare genetic disease which causes widespread inflammation in the body and has a poor prognosis due to various complications, especially respiratory system involvement. The aim of this study was to estimate the incidence of cystic fibrosis and determine its epidemiological, clinical and paraclinical features in Kurdistan province, Iran, between 2010 and 2020.
Materials and Methods: This cross-sectional study included cystic fibrosis patients admitted to Besat Hospital in Sanandaj (as the only referral specialized center for pediatric diseases in Kurdistan Province) between 2010 and 2011. Epidemiological, clinical and paraclinical data of the patients were collected by a checklist. Using SPSS software version 22, data were analyzed by using Mann-Whitney test and Spearman correlation coefficient.
Results: During the study period, we found 19 patients with definite diagnosis of cystic fibrosis, 14 (73.7%) male and 5 (26.3%) female, with mean age ± standard deviation of 11.10 ± 9.7. Based on the data of the birth rate in kurdistan Province during the study period, the incidence of cystic fibrosis in Kurdistan Province was estimated to be one in 15,000 live births per year. 4 patients (21.1%), had positive family history. The main symptoms of these patients were steatorrhea (94.7%), cough (89.5%), dyspnea (78.9%), growth disorder (73.7%), heart disorders (63.2%), jaundice (57.9%) and finger clubbing (36.8%).
Conclusion: Although cystic fibrosis is not very common in this province, identifying at-risk parents and early diagnosis of the disease can be beneficial for increasing life expectancy and quality of life and reducing health costs.
|
|
| Keywords: Cystic fibrosis, Genetic disorder, Incidence, Kurdistan |
|
|
Full-Text [PDF 1211 kb]
(285 Downloads)
|
Type of Study: Original Research |
Subject:
Medicine - Pediatric
Received: 2021/04/14 | Accepted: 2021/11/24 | Published: 2023/03/3
|
|
|
|
|
|
|
| References |
1. Row S, Miller S, Sorscher E. Mechanisms of disease; cystic fibrosis. N Engl J Med. 2005;352:1992-2001. [ DOI:10.1056/NEJMra043184] [ PMID] 2. Keating CL, Liu X, DiMango EA. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest. 2010;137(5):1157-63. [ DOI:10.1378/chest.09-1352] [ PMID] [ ] 3. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995;269(5225):847-50. [ DOI:10.1126/science.7543698] [ PMID] 4. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nature medicine. 2012;18(4):509. [ DOI:10.1038/nm.2715] [ PMID] [ ] 5. O'Sullivan BP1, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891-904. [ DOI:10.1016/S0140-6736(09)60327-5] [ PMID] 6. Hamosh A, FitzSimmons SC, Macek Jr M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. The Journal of pediatrics. 1998;132(2):255-9. [ DOI:10.1016/S0022-3476(98)70441-X] [ PMID] 7. Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes & metabolism. 2005;31(3):221-32. [ DOI:10.1016/S1262-3636(07)70189-1] [ PMID] 8. Corriveau S, Sykes J, Stephenson AL. Cystic fibrosis survival: the changing epidemiology. Current opinion in pulmonary medicine. 2018;24(6):574-8. [ DOI:10.1097/MCP.0000000000000520] [ PMID] 9. Rosenstein BJ, Zeitlin PL. Prognosis in cystic fibrosis. Current Opinion in Pulmonary Medicine. 1995;1(6):444-9. [ DOI:10.1097/00063198-199511000-00003] [ PMID] 10. Denning CR, Huang NN, Cuasay L, Shwachman H, Tocci P, Warwick WJ, et al. Cooperative study comparing three methods of performing sweat tests to diagnose cystic fibrosis. Pediatrics. 1980;66(5):752-7. [ DOI:10.1542/peds.66.5.752] [ PMID] 11. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. The Journal of pediatrics. 2017;181:S4-S15. e1. [ DOI:10.1016/j.jpeds.2016.09.064] [ PMID] 12. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. The Journal of pediatrics. 2008;153(2):S4-S14. [ DOI:10.1016/j.jpeds.2008.05.005] [ PMID] [ ] 13. Hosseinzadeh SS, Rafeey M, Vahedi L, Noorazar SG. The Frequency of Psychiatric Disorders in Cystic Fibrosis Patients Aged 5-18 Years in Northwest of Iran. Crescent Journal of Medical and Biological Sciences. 2019;6(1):56-60. 14. Rahmani K, Zokaei M, Bidarpoor F, Babahajiani S, Nessaei P, Moradi G. Children mortality rate trend in kurdistan province during 2007 to 2011. Iranian Journal of Epidemiology. 2014;10(1):65-72. 15. Dupuis A, Hamilton D, Cole DE, Corey M. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing. The Journal of pediatrics. 2005;147(3):312-5. [ DOI:10.1016/j.jpeds.2005.06.043] [ PMID] 16. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest. 2004;126(4):1215-24. [ DOI:10.1378/chest.126.4.1215] [ PMID] 17. Super M, Barnes R, Greig D. Failure to refer for testing for cystic fibrosis: Doctors must ensure that those with a family history are advised appropriately. British Medical Journal Publishing Group; 2001. [ DOI:10.1136/bmj.322.7282.310] [ PMID] [ ] 18. Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in cystic fibrosis. Journal of Cystic Fibrosis. 2017;16:S70-S8. [ DOI:10.1016/j.jcf.2017.06.011] [ PMID] 19. Chang AB, Phelan PD, Sawyer SM, Del Brocco S, Robertson CF. Cough sensitivity in children with asthma, recurrent cough, and cystic fibrosis. Archives of disease in childhood. 1997;77(4):331-4. [ DOI:10.1136/adc.77.4.331] [ PMID] [ ] 20. Giglio L, Candusso M, D'orazio C, Mastella G, Faraguna D. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatrica. 1997;86(11):1162-5. [ DOI:10.1111/j.1651-2227.1997.tb14836.x] [ PMID] 21. von Drygalski A, Biller J. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutrition in Clinical Practice. 2008;23(5):557-63. [ DOI:10.1177/0884533608323426] [ PMID] 22. Bright-Thomas RJ, Webb AK. The heart in cystic fibrosis. Journal of the Royal Society of Medicine. 2002;95(Suppl 41):2. 23. Valman H, France N, Wallis P. Prolonged neonatal jaundice in cystic fibrosis. Archives of disease in childhood. 1971;46(250):805-9. [ DOI:10.1136/adc.46.250.805] [ PMID] [ ] 24. Lykavieris P, Bernard O, Hadchouel M. Neonatal cholestasis as the presenting feature in cystic fibrosis. Archives of disease in childhood. 1996;75(1):67-70. [ DOI:10.1136/adc.75.1.67] [ PMID] [ ] 25. Muñiz AE, Bartle S, Foster R. Edema, anemia, hypoproteinemia, and acrodermatitis enteropathica: an uncommon initial presentation of cystic fibrosis. Pediatric emergency care. 2004;20(2):112-4. [ DOI:10.1097/01.pec.0000113881.10140.50] [ PMID] 26. Pitts-Tucker T, Miller M, Littlewood J. Finger clubbing in cystic fibrosis. Archives of disease in childhood. 1986;61(6):576-9. [ DOI:10.1136/adc.61.6.576] [ PMID] [ ] 27. Nakamura CT, Ng GY, Paton JY, Keens TG, Witmer JC, Bautista‐Bolduc D, et al. Correlation between digital clubbing and pulmonary function in cystic fibrosis. Pediatric pulmonology. 2002;33(5):332-8. [ DOI:10.1002/ppul.10082] [ PMID] 28. Merkel PA. Rheumatic disease and cystic fibrosis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1999;42(8):1563-71.
https://doi.org/10.1002/1529-0131(199908)42:8<1563::AID-ANR1>3.0.CO;2-H [ DOI:10.1002/1529-0131(199908)42:83.0.CO;2-H] [ PMID] 29. Wang X, Moylan B, Leopold DA, Kim J, Rubenstein RC, Togias A, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. Jama. 2000;284(14):1814-9. [ DOI:10.1001/jama.284.14.1814] [ PMID] 30. Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. Journal of allergy and clinical immunology. 1992;90(3):547-52. [ DOI:10.1016/0091-6749(92)90183-3] [ PMID] 31. Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis. Current opinion in pulmonary medicine. 2008;14(6):582-8. [ DOI:10.1097/MCP.0b013e3283121cf1] [ PMID] 32. Bass S, Connon J, Ho C. Biliary tree in cystic fibrosis: biliary tract abnormalities in cystic fibrosis demonstrated by endoscopic retrograde cholangiography. Gastroenterology. 1983;84(6):1592-6. [ DOI:10.1016/0016-5085(83)90386-4] [ PMID] 33. Leung DH, Yimlamai D. The intestinal microbiome and paediatric liver disease. The Lancet Gastroenterology & Hepatology. 2017;2(6):446-55. [ DOI:10.1016/S2468-1253(16)30241-2] [ PMID] 34. Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Annals of Otology, Rhinology & Laryngology. 2002;111(12):1081-6. [ DOI:10.1177/000348940211101204] [ PMID] 35. Ozcelik U, Besbas N, Gocmen A, Akata D, Akhan O, Ozguc M, et al. Hypercalciuria and nephrocalcinosis in cystic fibrosis patients. TURKISH JOURNAL OF PEDIATRICS. 2004;46(1):22-7. 36. Nazareth D, Walshaw M. A review of renal disease in cystic fibrosis. Journal of Cystic Fibrosis. 2013;12(4):309-17. [ DOI:10.1016/j.jcf.2013.03.005] [ PMID] 37. Stonebraker JR, Ooi CY, Pace RG, Corvol H, Knowles MR, Durie PR, et al. Features of severe liver disease with portal hypertension in patients with cystic fibrosis. Clinical Gastroenterology and Hepatology. 2016;14(8):1207-15. e3. [ DOI:10.1016/j.cgh.2016.03.041] [ PMID] [ ] 38. Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis. 2011;10:S29-S36. [ DOI:10.1016/S1569-1993(11)60006-4] [ PMID] 39. Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, et al. Aspartate aminotransferase to platelet ratio and fibrosis‐4 as biomarkers in biopsy‐validated pediatric cystic fibrosis liver disease. Hepatology. 2015;62(5):1576-83. [ DOI:10.1002/hep.28016] [ PMID] 40. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest. 2005;128(2):729-38. [ DOI:10.1378/chest.128.2.729] [ PMID] 41. Taylor-Cousar JL, Zariwala MA, Burch LH, Pace RG, Drumm ML, Calloway H, et al. Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. PloS one. 2009;4(1). [ DOI:10.1371/journal.pone.0004270] [ PMID] [ ] 42. El-Chammas KI, Rumman N, Goh VL, Quintero D, Goday PS. Rectal prolapse and cystic fibrosis. Journal of pediatric gastroenterology and nutrition. 2015;60(1):110-2. [ DOI:10.1097/MPG.0000000000000546] [ PMID] 43. Hamid B, Khan A. Cerebral hemorrhage as the initial manifestation of cystic fibrosis. Journal of child neurology. 2007;22(1):114-5. [ DOI:10.1177/0883073807299957] [ PMID] 44. Snell GI, Bennetts K, Bartolo J, Levvey B, Griffiths A, Williams T, et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 1998;17(11):1097-103. 45. Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of pediatrics. 2009;155(6):S73-S93. [ DOI:10.1016/j.jpeds.2009.09.001] [ PMID] [ ] 46. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. New England Journal of Medicine. 1992;326(18):1187-91. [ DOI:10.1056/NEJM199204303261804] [ PMID] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Ethics code: IR.MUK.REC.1399.145
Yazdanpanah H, Ataee P, Ahmadi Hedayati M, Servatyari K, Rahmani K. Estimation of Incidence and Evaluation of Clinical and Paraclinical Features of Cystic Fibrosis: A Rare Disease in Kurdistan Province between 2010 and 2020. SJKU 2023; 27 (6) :54-67 URL: http://sjku.muk.ac.ir/article-1-6682-en.html
|
